An implantable drainage device is provided. The device is adapted to move body fluid from one part of the body of a patient to another part of the body.

The present invention relates to an implantable apparatus for obtaining urinary control and emptying of the urinary bladder, thereby preventing from or treating involuntary urinary retention. In general terms, the apparatus comprises an expandable member adapted to be implanted inside the urinary bladder of the patient for discharging urine, and a control device for controlling the volume of the expandable member. The control device is adapted to be connected to the expandable member through the wall of the urinary bladder.

A medical device including an artificial contractile structure which may be advantageously used to assist the functioning of a hollow organ. Specifically, the medical device includes an artificial contractile structure with at least one contractile element adapted to contract an organ, in such way that the contractile element is in a resting or in an activated position, at least one actuator designed to activate the contractile structure, and at least one source of energy for powering the actuator. The medical device also includes a means for reducing corrosion of the medical device hence reducing the risk of the device dysfunction and patient contamination.

The present disclosure relates generally to systems, components, devices and methods for assisting a patient to empty his or her weakened or paralyzed bladder or a neobladder efficiently. The system and method includes a pressure sensor for sensing the pressure in the urinary bladder of a patient and an alert mechanism which alerts the patient of the bladder fullness and the need to void. An actuating device is operably coupled to the system to selectively activate a compression assembly. When activated, the compression assembly compresses the bladder to permit emptying of the bladder.

A method is provided for maintaining the position of pelvic organs, such as components of the urinary tract. The method may involve anchoring the pelvic organs by inserting the implant via an anterior approach, avoiding complications and side effects that result when implants are inserted through the wall of the vagina.

A product for implantation within a soft tissue site of the human or animal body comprises a matrix of pulverized or morselized substantially non-mineralized native soft tissue (NSTM) of the human or animal body, provided in a therapeutic amount to induce growth of native tissue or organs and healing at the tissue site. The NSTM is composed of at least one soft tissue selected from the group consisting of cartilage, meniscus, intervertebral disc, ligament, tendon, muscle, fascia, periosteum, pericardium, perichondrium, skin, nerve, blood vessels, and heart valves or from organs such as bladder, lung, kidney, liver, pancreas, thyroid, or thymus. Preferably, the NSTM is composed of a soft tissue of the same type of tissue native to the repair site.

The present invention relates to a sutureless method of repairing soft tissue defects in soft tissue including ligaments such as anterior cruciate ligaments (ACLs). In particular, the present invention relates a sutureless method of repairing soft tissue defect comprising: (i) providing a collagen-containing patch adapted to enclose at least a portion of said soft tissue defect; (ii) contacting said soft tissue defect and/or collagen-containing patch with a sensitizer; (Hi) enclosing said soft tissue defect in said collagen-containing patch to produce a bioactive chamber; and (iv) adhering said collagen-containing patch to said soft tissue defect without sutures.

A system includes an adjustable implant configured for implantation internally within a subject and includes a permanent magnet configured for rotation about an axis of rotation, the permanent magnet operatively coupled to a drive transmission configured to alter a dimension of the adjustable implant. The system includes an external adjustment device configured for placement on or adjacent to the skin of the subject having at least one magnet configured for rotation, the external adjustment device further comprising a motor configured to rotate the at least one magnet and an encoder. Rotation of the at least one magnet of the external adjustment device effectuates rotational movement of the permanent magnet of the adjustable implant and alters the dimension of the adjustable implant. Drive control circuitry is configured to receive an input signal from the encoder.

A medical device includes an artificial contractile structure which may be advantageously used to assist the functioning of a hollow organ, an artificial contractile structure including at least one contractile element (100) adapted to contract an organ, in such way that the contractile element (100) is in a resting or in an activated position, at least one actuator designed to activate the contractile structure, and at least one source of energy for powering the actuator. The ratio “current which is needed to maintain the contractile element in its activated position and in its resting position/current which is needed to change the position of the contractile element” is less than 1/500, preferably less than 1/800, and more preferably less than 1/1000. The medical device further includes elements for reducing corrosion of the medical device.

According to some embodiments, systems and methods are provided for non-invasively detecting the force generated by a non-invasively adjustable implantable medical device and/or a change in dimension of a non-invasively adjustable implantable medical device. Some of the systems include a non-invasively adjustable implant, which includes a driven magnet, and an external adjustment device, which includes one or more driving magnets and one or more Hall effect sensors. The Hall effect sensors of the external adjustment device are configured to detect changes in the magnetic field between the driven magnet of the non-invasively adjustable implant and the driving magnet(s) of the external adjustment device. Changes in the magnetic fields may be used to calculate the force generated by and/or a change in dimension of the non-invasively adjustable implantable medical device.